The House of Lords must alert the government about evidence showing that “long covid” (which includes debilitating fatigue and negative health effects) might last for years among sufferers, posing a long-term risk to the nation’s workforce and economy. This report discusses evidence that viruses can trigger long-term fatigue that severely impairs the personal and occupational functioning of sufferers, including evidence from populations affected by SARSCoV-1 where 1 in 4 had debilitating chronic fatigue lasting over 4 years later. Due to post-viral chronic fatigue being a condition that can force people into becoming housebound or unable to work, the House of Lords must alert the government of the risks currently facing people within the U...
In this paper, we explore the relationship between health risks from COVID-19 and UK labour supply. ...
OBJECTIVE: Characterization of the clinical features of patients with persistent symptoms after mild...
Although the majority of patients with COVID-19 will experience mild to moderate symptoms and will r...
A subset of patients has long-lasting symptoms after mild to moderate Coronavirus disease 2019 (COVI...
Previous efforts to estimate the burden of fatigue-related symptoms due to long COVID have a very hi...
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (so...
Objectives: The COVID-19 pandemic poses a significant economic burden on society worldwide. This bur...
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (so...
Contains fulltext : 245464.pdf (Publisher’s version ) (Open Access)Fatigue is a do...
There has been extensive research on post-viral fatigue, and the present mini-review and commentary ...
BACKGROUND: Chronic fatigue syndrome is a persistent and debilitating disorder. According to several...
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (so...
Background : Severe fatigue can persist for months after coronavirus disease 2019 (COVID-19) onset. ...
BACKGROUND The burden of long-term symptoms (ie, long COVID) in patients after mild COVID-19 is d...
Introduction Post-COVID-19 syndrome affects approximately 10-25% of people suffering from COVID-1...
In this paper, we explore the relationship between health risks from COVID-19 and UK labour supply. ...
OBJECTIVE: Characterization of the clinical features of patients with persistent symptoms after mild...
Although the majority of patients with COVID-19 will experience mild to moderate symptoms and will r...
A subset of patients has long-lasting symptoms after mild to moderate Coronavirus disease 2019 (COVI...
Previous efforts to estimate the burden of fatigue-related symptoms due to long COVID have a very hi...
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (so...
Objectives: The COVID-19 pandemic poses a significant economic burden on society worldwide. This bur...
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (so...
Contains fulltext : 245464.pdf (Publisher’s version ) (Open Access)Fatigue is a do...
There has been extensive research on post-viral fatigue, and the present mini-review and commentary ...
BACKGROUND: Chronic fatigue syndrome is a persistent and debilitating disorder. According to several...
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (so...
Background : Severe fatigue can persist for months after coronavirus disease 2019 (COVID-19) onset. ...
BACKGROUND The burden of long-term symptoms (ie, long COVID) in patients after mild COVID-19 is d...
Introduction Post-COVID-19 syndrome affects approximately 10-25% of people suffering from COVID-1...
In this paper, we explore the relationship between health risks from COVID-19 and UK labour supply. ...
OBJECTIVE: Characterization of the clinical features of patients with persistent symptoms after mild...
Although the majority of patients with COVID-19 will experience mild to moderate symptoms and will r...